TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / RxSight Stock

RxSight Stock

rxsight.comHealthcare / Medical DevicesFunding to Date: $179.84MM

RxSight is the developer of the first and only adjustable intraocular lens (IOL) that is customized after cataract surgery, enabling doctors and patients to predictably optimize vision after cataract surgery through an office based IOL enhancement.

Learn more about RxSight IPO

Register To Buy and Sell Shares

For more details on financing and valuation for RxSight, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access RxSight’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like RxSight.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Shelley Thunen
Chief Financial Officer
Robert Grubbs
Co-Founder
Ronald Kurtz MD
Chief Executive Officer, President & Board Member
Christian Sandstedt Ph.D
Vice President, Optics Research & Development
Matthew Haller Ph.D
Chief Technology Officer
Eric Weinberg
Chief Commercial Officer

Board Members

Christopher Cox JD
Werner Wolfen
Javier Perez-Sala
Bruce Robertson Ph.D
H.I.G. BioHealth Partners
J. Corley
Ronald Kurtz MD
Juliet Bakker
Longitude Capital
Jan Bonel
Daniel Schwartz
William Link Ph.D
Flying L Partners
Joseph Devivo
James Adler

Other companies like RxSight in the Medical Devices sector

Neuralink

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$3.45B

Synchron

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$400.53MM

HistoSonics

Sector
Healthcare / Medical Devices
 
 

Levels

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$310.36MM

Beta Bionics

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$263MM

CMR Surgical

Sector
Healthcare / Medical Devices
 
 

Imperative Care

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$1.35B

Eko Health

Sector
Healthcare / Medical Devices
Last Round Est. Valuation
$268.75MM

Verily Life Sciences

Sector
Healthcare / Medical Devices
 
 

News Highlights

The Wall Street Journal 06/04/2015
Calhoun Vision Raises $69M, Advances Novel Lenses for Cataract Patients
Venture investors are providing $69 million to Calhoun Vision Inc. and betting that its technology will make it stand out in a crowded market for artificial lenses used in cataract patients.

Trending Companies

Frequently Asked Questions

Updated on: Apr 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.